Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...

Piramal Pharma is utilising a capex of about USD 85 million for various initiatives, including capacity expansion, ...

Investments will target both domestic and US markets, with a split allocation for maintenance and capacity expansion in key ...

Piramal Pharma, aiming for USD 2 billion revenue by FY30, will invest USD 85 million in capex this fiscal for capacity ...

Piramal Pharma is investing USD 85 million this fiscal for expansion and maintenance, with USD 30 million already spent in ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...

Revenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, ...